Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
democrats
3
×
detroit blog main
detroit top stories
fda
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
clinical study
commissioner
crispr
failure
gene editing
gene therapy
glaxosmithkline
indiana blog main
indiana top stories
ipo
novartis
scott gottlieb
What
bio
3
×
roundup
crispr
ipo
moves
week
allogene
america
big
biogen
bosley's
bosley’s
bridge
bucks
cancer
cas
ceo
continues
convoluted
crime
democrats
departure
diversity
dreams
editas
exit
guiding
head
headaches
healthcare
holding
hot
immunotherapy
insurance
investors
juno
katrine
medicine
million
nearly
Language
Current search:
democrats
×
biotech
×
bio
×
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More